Annual Accounts Receivable
$773.00 K
+$485.00 K+168.40%
December 31, 2024
Summary
- As of March 10, 2025, CRDF annual accounts receivable is $773.00 thousand, with the most recent change of +$485.00 thousand (+168.40%) on December 31, 2024.
- During the last 3 years, CRDF annual accounts receivable has risen by +$238.00 thousand (+44.49%).
- CRDF annual accounts receivable is now at all-time high.
Performance
CRDF Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$773.00 K
+$155.00 K+25.08%
December 31, 2024
Summary
- As of March 10, 2025, CRDF quarterly accounts receivable is $773.00 thousand, with the most recent change of +$155.00 thousand (+25.08%) on December 31, 2024.
- Over the past year, CRDF quarterly accounts receivable has increased by +$155.00 thousand (+25.08%).
- CRDF quarterly accounts receivable is now at all-time high.
Performance
CRDF Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CRDF Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +168.4% | +25.1% |
| 3 y3 years | +44.5% | +72.9% |
| 5 y5 years | +279.9% | +72.9% |
CRDF Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +168.4% | at high | +380.1% |
| 5 y | 5-year | at high | +279.9% | at high | +626.5% |
| alltime | all time | at high | +1263.3% | at high | +1268.1% |
Cardiff Oncology Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $773.00 K(+168.4%) | $773.00 K(+25.1%) |
| Sep 2024 | - | $618.00 K(+37.0%) |
| Jun 2024 | - | $451.00 K(+14.8%) |
| Mar 2024 | - | $393.00 K(+36.5%) |
| Dec 2023 | $288.00 K(-62.6%) | $288.00 K(+45.5%) |
| Sep 2023 | - | $198.00 K(+23.0%) |
| Jun 2023 | - | $161.00 K(-76.2%) |
| Mar 2023 | - | $676.00 K(-12.3%) |
| Dec 2022 | $771.00 K(+44.1%) | $771.00 K(+18.6%) |
| Sep 2022 | - | $650.00 K(+18.0%) |
| Jun 2022 | - | $551.00 K(+23.3%) |
| Mar 2022 | - | $447.00 K(-16.4%) |
| Dec 2021 | $535.00 K(+67.2%) | $535.00 K(+35.4%) |
| Sep 2021 | - | $395.00 K(+28.2%) |
| Jun 2021 | - | $308.00 K(+27.3%) |
| Mar 2021 | - | $242.00 K(-24.4%) |
| Dec 2020 | $320.00 K(+57.2%) | $320.00 K(+56.6%) |
| Sep 2020 | - | $204.40 K(+87.0%) |
| Jun 2020 | - | $109.30 K(+2.7%) |
| Mar 2020 | - | $106.40 K(-47.7%) |
| Dec 2019 | $203.50 K(+21.3%) | $203.50 K(+33.9%) |
| Sep 2019 | - | $152.00 K(+24.3%) |
| Jun 2019 | - | $122.30 K(+5.7%) |
| Mar 2019 | - | $115.70 K(-31.0%) |
| Dec 2018 | $167.80 K | $167.80 K(+30.5%) |
| Sep 2018 | - | $128.60 K(+3.6%) |
| Jun 2018 | - | $124.10 K(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $114.30 K(+48.2%) |
| Dec 2017 | $77.10 K(-23.3%) | $77.10 K(-56.7%) |
| Sep 2017 | - | $178.10 K(+13.2%) |
| Jun 2017 | - | $157.40 K(+96.0%) |
| Mar 2017 | - | $80.30 K(-20.1%) |
| Dec 2016 | $100.50 K(+1.8%) | $100.50 K(+18.0%) |
| Sep 2016 | - | $85.20 K(-46.2%) |
| Jun 2016 | - | $158.50 K(+156.1%) |
| Mar 2016 | - | $61.90 K(-37.3%) |
| Dec 2015 | $98.70 K(+74.1%) | $98.70 K(+47.3%) |
| Sep 2015 | - | $67.00 K(-32.8%) |
| Jun 2015 | - | $99.70 K(+67.8%) |
| Mar 2015 | - | $59.40 K(+4.8%) |
| Dec 2014 | $56.70 K(-28.2%) | $56.70 K(-9.1%) |
| Sep 2014 | - | $62.40 K(+4.2%) |
| Jun 2014 | - | $59.90 K(-53.7%) |
| Mar 2014 | - | $129.30 K(+63.7%) |
| Dec 2013 | $79.00 K(-53.1%) | $79.00 K(+13.5%) |
| Sep 2013 | - | $69.60 K(+23.2%) |
| Jun 2013 | - | $56.50 K(-2.8%) |
| Mar 2013 | - | $58.10 K(-65.5%) |
| Dec 2012 | $168.40 K(+69.9%) | $168.40 K(+31.4%) |
| Sep 2012 | - | $128.20 K(+20.9%) |
| Jun 2012 | - | $106.00 K(+38.6%) |
| Mar 2012 | - | $76.50 K(-22.8%) |
| Dec 2011 | $99.10 K(+32.1%) | $99.10 K |
| Dec 2010 | $75.00 K | - |
FAQ
- What is Cardiff Oncology annual accounts receivable?
- What is the all time high annual accounts receivable for Cardiff Oncology?
- What is Cardiff Oncology annual accounts receivable year-on-year change?
- What is Cardiff Oncology quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cardiff Oncology?
- What is Cardiff Oncology quarterly accounts receivable year-on-year change?
What is Cardiff Oncology annual accounts receivable?
The current annual accounts receivable of CRDF is $773.00 K
What is the all time high annual accounts receivable for Cardiff Oncology?
Cardiff Oncology all-time high annual accounts receivable is $773.00 K
What is Cardiff Oncology annual accounts receivable year-on-year change?
Over the past year, CRDF annual accounts receivable has changed by +$485.00 K (+168.40%)
What is Cardiff Oncology quarterly accounts receivable?
The current quarterly accounts receivable of CRDF is $773.00 K
What is the all time high quarterly accounts receivable for Cardiff Oncology?
Cardiff Oncology all-time high quarterly accounts receivable is $773.00 K
What is Cardiff Oncology quarterly accounts receivable year-on-year change?
Over the past year, CRDF quarterly accounts receivable has changed by +$155.00 K (+25.08%)